trabedersen

FDA and EMEA Grant Orphan Drug Designation for Antisense Pharma's Investigational Drug Trabedersen in Pancreatic Carcinoma
Reuters
Mon, 09/14/09 - 10:34 am
FDA
EMEA
orphan drugs
antisense
trabedersen
pancreatic cancer